Aadi Change To Account Receivables vs End Period Cash Flow Analysis

AADI Stock

USD 2.36 0.05 2.07%

Aadi Bioscience financial indicator trend analysis is way more than just evaluating Aadi Bioscience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aadi Bioscience is a good investment. Please check the relationship between Aadi Bioscience Change To Account Receivables and its End Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Change To Account Receivables vs End Period Cash Flow

Change To Account Receivables vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aadi Bioscience Change To Account Receivables account and End Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Aadi Bioscience's Change To Account Receivables and End Period Cash Flow is 0.44. Overlapping area represents the amount of variation of Change To Account Receivables that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Aadi Bioscience, assuming nothing else is changed. The correlation between historical values of Aadi Bioscience's Change To Account Receivables and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Account Receivables of Aadi Bioscience are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Change To Account Receivables i.e., Aadi Bioscience's Change To Account Receivables and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.44

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Change To Account Receivables

End Period Cash Flow

Most indicators from Aadi Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Enterprise Value Multiple is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	105K	159K	171K	122.1K
Interest Income	13K	2.4M	6.5M	6.8M

Reconciled Depreciation Interest Income

Aadi Bioscience fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Current Assets	Short Long Term Debt Total	Total Current Liabilities	Other Assets	Non Current Liabilities Total	Total Liab	Short Term Debt	Common Stock	Other Current Liab	Accounts Payable	Other Current Assets	Non Current Assets Total	Non Currrent Assets Other	Property Plant And Equipment Net	Current Deferred Revenue	Short Term Investments	Common Stock Total Equity	Property Plant And Equipment Gross
Total Assets		0.99	-0.79	-0.85	0.8	1.0	0.84	0.95	1.0	-0.11	0.65	0.93	0.81	0.73	-0.21	0.45	0.88	0.88	0.96	0.88	0.96	0.67	0.74	0.73	-0.39	0.66
Total Stockholder Equity	0.99		-0.81	-0.83	0.81	1.0	0.8	0.94	0.99	-0.23	0.53	0.9	0.8	0.63	-0.32	0.48	0.85	0.83	0.95	0.85	0.95	0.63	0.7	0.73	-0.44	0.62
Net Debt	-0.79	-0.81		0.63	-1.0	-0.8	-0.45	-0.74	-0.78	0.28	-0.35	-0.69	-0.62	-0.43	0.33	-0.56	-0.58	-0.77	-0.83	-0.72	-0.75	-0.38	-0.66	-0.19	0.26	-0.37
Retained Earnings	-0.85	-0.83	0.63		-0.66	-0.83	-0.85	-0.95	-0.85	0.0	-0.68	-0.83	-0.44	-0.7	0.1	-0.56	-0.93	-0.8	-0.85	-0.84	-0.8	-0.82	-0.8	-0.61	0.27	-0.81
Cash	0.8	0.81	-1.0	-0.66		0.81	0.48	0.75	0.8	-0.19	0.42	0.72	0.63	0.5	-0.25	0.54	0.61	0.8	0.84	0.75	0.76	0.4	0.68	0.2	-0.24	0.4
Cash And Short Term Investments	1.0	1.0	-0.8	-0.83	0.81		0.79	0.93	1.0	-0.15	0.58	0.9	0.83	0.68	-0.24	0.47	0.84	0.84	0.95	0.84	0.95	0.61	0.72	0.73	-0.41	0.6
Common Stock Shares Outstanding	0.84	0.8	-0.45	-0.85	0.48	0.79		0.88	0.83	-0.05	0.7	0.93	0.48	0.72	-0.17	0.19	0.97	0.82	0.83	0.91	0.87	0.94	0.58	0.75	-0.46	0.94
Other Stockholder Equity	0.95	0.94	-0.74	-0.95	0.75	0.93	0.88		0.95	-0.16	0.64	0.91	0.6	0.69	-0.26	0.58	0.94	0.86	0.93	0.89	0.9	0.79	0.82	0.68	-0.31	0.79
Total Current Assets	1.0	0.99	-0.78	-0.85	0.8	1.0	0.83	0.95		-0.11	0.64	0.93	0.81	0.73	-0.21	0.46	0.87	0.87	0.96	0.87	0.95	0.66	0.74	0.74	-0.38	0.65
Short Long Term Debt Total	-0.11	-0.23	0.28	0.0	-0.19	-0.15	-0.05	-0.16	-0.11		0.55	-0.05	-0.02	0.5	0.99	-0.28	-0.05	0.02	-0.14	-0.07	-0.11	-0.03	0.02	-0.03	0.31	-0.03
Total Current Liabilities	0.65	0.53	-0.35	-0.68	0.42	0.58	0.7	0.64	0.64	0.55		0.72	0.43	0.99	0.44	0.13	0.71	0.79	0.61	0.7	0.63	0.68	0.68	0.47	0.02	0.68
Other Assets	0.93	0.9	-0.69	-0.83	0.72	0.9	0.93	0.91	0.93	-0.05	0.72		0.69	0.78	-0.17	0.21	0.94	0.95	0.95	0.98	0.98	0.83	0.63	0.67	-0.51	0.83
Non Current Liabilities Total	0.81	0.8	-0.62	-0.44	0.63	0.83	0.48	0.6	0.81	-0.02	0.43	0.69		0.57	-0.07	0.16	0.47	0.63	0.73	0.56	0.78	0.19	0.44	0.68	-0.4	0.18
Total Liab	0.73	0.63	-0.43	-0.7	0.5	0.68	0.72	0.69	0.73	0.5	0.99	0.78	0.57		0.39	0.15	0.73	0.83	0.69	0.74	0.71	0.65	0.7	0.55	-0.05	0.65
Short Term Debt	-0.21	-0.32	0.33	0.1	-0.25	-0.24	-0.17	-0.26	-0.21	0.99	0.44	-0.17	-0.07	0.39		-0.3	-0.17	-0.09	-0.23	-0.19	-0.22	-0.15	-0.07	-0.11	0.32	-0.15
Common Stock	0.45	0.48	-0.56	-0.56	0.54	0.47	0.19	0.58	0.46	-0.28	0.13	0.21	0.16	0.15	-0.3		0.33	0.29	0.36	0.22	0.23	0.17	0.78	0.16	0.3	0.17
Other Current Liab	0.88	0.85	-0.58	-0.93	0.61	0.84	0.97	0.94	0.87	-0.05	0.71	0.94	0.47	0.73	-0.17	0.33		0.86	0.89	0.94	0.89	0.93	0.67	0.68	-0.42	0.93
Accounts Payable	0.88	0.83	-0.77	-0.8	0.8	0.84	0.82	0.86	0.87	0.02	0.79	0.95	0.63	0.83	-0.09	0.29	0.86		0.91	0.96	0.92	0.77	0.74	0.47	-0.35	0.77
Other Current Assets	0.96	0.95	-0.83	-0.85	0.84	0.95	0.83	0.93	0.96	-0.14	0.61	0.95	0.73	0.69	-0.23	0.36	0.89	0.91		0.94	0.97	0.72	0.66	0.61	-0.49	0.72
Non Current Assets Total	0.88	0.85	-0.72	-0.84	0.75	0.84	0.91	0.89	0.87	-0.07	0.7	0.98	0.56	0.74	-0.19	0.22	0.94	0.96	0.94		0.95	0.87	0.62	0.53	-0.5	0.87
Non Currrent Assets Other	0.96	0.95	-0.75	-0.8	0.76	0.95	0.87	0.9	0.95	-0.11	0.63	0.98	0.78	0.71	-0.22	0.23	0.89	0.92	0.97	0.95		0.73	0.6	0.69	-0.58	0.73
Property Plant And Equipment Net	0.67	0.63	-0.38	-0.82	0.4	0.61	0.94	0.79	0.66	-0.03	0.68	0.83	0.19	0.65	-0.15	0.17	0.93	0.77	0.72	0.87	0.73		0.54	0.52	-0.36	1.0
Current Deferred Revenue	0.74	0.7	-0.66	-0.8	0.68	0.72	0.58	0.82	0.74	0.02	0.68	0.63	0.44	0.7	-0.07	0.78	0.67	0.74	0.66	0.62	0.6	0.54		0.41	0.16	0.54
Short Term Investments	0.73	0.73	-0.19	-0.61	0.2	0.73	0.75	0.68	0.74	-0.03	0.47	0.67	0.68	0.55	-0.11	0.16	0.68	0.47	0.61	0.53	0.69	0.52	0.41		-0.41	0.51
Common Stock Total Equity	-0.39	-0.44	0.26	0.27	-0.24	-0.41	-0.46	-0.31	-0.38	0.31	0.02	-0.51	-0.4	-0.05	0.32	0.3	-0.42	-0.35	-0.49	-0.5	-0.58	-0.36	0.16	-0.41		-0.35
Property Plant And Equipment Gross	0.66	0.62	-0.37	-0.81	0.4	0.6	0.94	0.79	0.65	-0.03	0.68	0.83	0.18	0.65	-0.15	0.17	0.93	0.77	0.72	0.87	0.73	1.0	0.54	0.51	-0.35

Click cells to compare fundamentals

Aadi Bioscience Account Relationship Matchups

Aadi Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	39.9M	18.8M	157.9M	184.2M	132.4M	139.0M
Total Stockholder Equity	36.5M	(12.4M)	136.4M	158.4M	105.2M	110.5M
Net Debt	(38.4M)	5.8M	(148.4M)	(37.4M)	(61.6M)	(58.5M)
Retained Earnings	(142.2M)	(32.6M)	(142.7M)	(203.2M)	(269.0M)	(255.5M)
Cash	38.5M	4.5M	149.0M	39.0M	62.9M	66.0M
Cash And Short Term Investments	38.5M	4.5M	149.0M	172.6M	108.8M	114.3M
Common Stock Shares Outstanding	2.7M	2.5M	8.9M	22.5M	26.9M	28.3M
Liabilities And Stockholders Equity	39.9M	18.8M	157.9M	184.2M	132.4M	139.0M
Other Stockholder Equity	179.1M	20.2M	279.1M	361.7M	374.1M	392.8M
Total Current Assets	39.6M	18.7M	151.3M	180.0M	124.6M	130.8M
Total Current Liabilities	3.3M	30.1M	15.3M	18.8M	26.4M	27.7M
Total Liab	3.4M	31.3M	21.5M	25.9M	27.2M	28.6M
Other Current Liab	2.8M	99K	8.7M	14.5M	20.1M	21.1M
Accounts Payable	439.8K	2.4M	6.4M	3.5M	5.9M	6.2M
Other Current Assets	1.0M	81K	4.6M	3.7M	3.8M	4.0M
Non Current Assets Total	366.3K	140K	6.6M	4.2M	7.8M	8.2M
Non Currrent Assets Other	40.0K	(140K)	2.2M	2.1M	1.9M	2.0M
Property Plant And Equipment Net	326.3K	140K	614K	2.0M	6.0M	6.3M
Accumulated Other Comprehensive Income	(335.8K)	(311.1K)	(328.9K)	(115K)	27K	28.4K
Property Plant And Equipment Gross	326.3K	185.6K	614K	2.0M	6.2M	6.6M
Net Tangible Assets	(9.1M)	43.1M	132.6M	158.4M	182.1M	191.2M
Property Plant Equipment	316.0K	121.7K	57K	2.0M	2.3M	2.5M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:

How To Invest In Aadi

Details

Is Aadi Stock a good investment?

Details

What is Aadi Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.28)

Revenue Per Share

0.929

Quarterly Revenue Growth

0.21

Return On Assets

(0.35)

Return On Equity

(0.66)

The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aadi Change To Account Receivables vs End Period Cash Flow Analysis

Change To Account Receivables vs End Period Cash Flow

Change To Account Receivables vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Change To Account Receivables

End Period Cash Flow

Aadi Bioscience fundamental ratios Correlations

Aadi Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aadi Bioscience fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Other Current Liab	- 0.93	Retained Earnings
Other Current Assets	- 0.85	Retained Earnings
Total Current Assets	- 0.85	Retained Earnings
Common Stock Shares Outstanding	- 0.85	Retained Earnings